Next-generation sequencing in childhood-onset epilepsies: Diagnostic yield and impact on neuronal ceroid lipofuscinosis type 2 (CLN2) disease diagnosis

• Kimberly Gall,

  Roles Data curation, Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Blueprint Genetics Inc, Seattle, Washington, United States of America

  https://orcid.org/0000-0001-9203-4985

  ⨯
• Emanuela Izzo,

  Roles Supervision, Writing – review & editing

  Affiliation Biomarin Pharmaceutical, Novato, California, United States of America

  ⨯
• Eija H. Seppälä,

  Roles Data curation, Writing – review & editing

  Affiliation Blueprint Genetics Oy, Espoo, Finland

  ⨯
• Kirsi Alakurtti,

  Roles Data curation, Writing – review & editing

  Affiliation Blueprint Genetics Oy, Espoo, Finland

  ⨯
• Lotta Koskinen,

  Roles Data curation, Writing – review & editing

  Affiliation Blueprint Genetics Oy, Espoo, Finland

  ⨯
• Inka Saarinen,

  Roles Data curation, Writing – review & editing

  Affiliation Blueprint Genetics Oy, Espoo, Finland

  https://orcid.org/0000-0001-8079-379X

  ⨯
• Akashdeep Singh,

  Roles Conceptualization, Writing – review & editing

  Affiliation Biomarin Pharmaceutical, Novato, California, United States of America

  https://orcid.org/0000-0002-5513-8352

  ⨯
• Samuel Myllykangas,

  Roles Methodology, Writing – review & editing

  Affiliation Blueprint Genetics Oy, Espoo, Finland

  ⨯
• Juha Koskenvuo,

  Roles Supervision, Writing – review & editing

  Affiliation Blueprint Genetics Oy, Espoo, Finland

  ⨯
• Tero-Pekka Alastalo

  Roles Conceptualization, Writing – original draft, Writing – review & editing

  * E-mail: tero-pekka.alastalo@blueprintgenetics.com

  Affiliation Blueprint Genetics Inc, Seattle, Washington, United States of America

  ⨯